Conference Coverage

Ask depressed patients about hypersomnia to screen for mixicity

Publish date: November 9, 2018

 

REPORTING FROM THE ECNP CONGRESS

The BRIDGE-II-MIX study was sponsored by Sanofi-Aventis. Dr. Murru reported having no financial conflicts of interest regarding the study.

Pages

Recommended Reading

Collaborative approach for suicidal youth helps providers, too
MDedge Family Medicine
Most Americans incorrectly identify homicide as more common than suicide
MDedge Family Medicine
FDA panels vote no on opioid-containing drug for MDD
MDedge Family Medicine
Interacting with horses helps veterans with PTSD; Identical twin battles anorexia
MDedge Family Medicine
FDA panels back brexanolone infusion for postpartum depression
MDedge Family Medicine
Novel theory explains SSRIs’ variable efficacy
MDedge Family Medicine
Identifying and stopping a likely mass shooter: A case study
MDedge Family Medicine
Lay counseling effective for reducing late-life depression
MDedge Family Medicine
Physical activity tied to lower depression risk among older adults
MDedge Family Medicine
Higher prenatal exposure to daylight tied to lower depression risk
MDedge Family Medicine